---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-101650"
form_type: "8-K"
ticker: "LRMR"
cik: "0001374690"
company_name: "Larimar Therapeutics, Inc."
filed_at: "2022-04-11T23:59:59+00:00"
generated_at: "2026-06-26T08:11:37.743703+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Larimar Therapeutics director Thomas O. Daniel not standing for re-election at 2022 Annual Meeting

## Summary
- Thomas O. Daniel, Ph.D., notified the Board he will not stand for re-election as a Class II director at the 2022 Annual Meeting.
- His departure is effective at the conclusion of the Annual Meeting; no reason given other than not standing for re-election.
- No disagreement with the Company's operations, policies, or practices.
- Dr. Daniel served on the Board and any committees; no replacement named yet.

## SEC filing metadata
- accession: 0001193125-22-101650
- form_type: 8-K
- ticker: LRMR
- cik: 0001374690
- company_name: Larimar Therapeutics, Inc.
- filed_at: 2022-04-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374690/000119312522101650/0001193125-22-101650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374690/000119312522101650/d334496d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-101650
- JSON: https://secwatch.observer/filing/0001193125-22-101650.json
- Plain text: https://secwatch.observer/filing/0001193125-22-101650.txt

## Key facts
- Executive change
  Thomas O. Daniel departed as Class II director at Larimar Therapeutics, Inc..
  - Action: not stand for re-election
  - Role: Class II director
  source text: On April 6, 2022, Thomas O. Daniel, Ph.D., a member of the Board of Directors (the “ Board ”) of Larimar Therapeutics, Inc. (the “ Company ”), notified the Company that he will not stand for re-election as a Class II director at the Company’s 2022 Annual Meeting of Stockholders (the “ Annual Meeting ”), and therefore, will no longer serve as a director of the Company or on any committee of the Board, effective as of the conclusion of the Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1374690/000119312522101650/0001193125-22-101650-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.